8-K
Current Report
Vir Biotechnology, Inc. Filed Acc 0001628280-24-034143
Results of operations · Exit or restructuring costs
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading vir-20240729.htm…